400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Anti-infection / HCV / GSK8175
CAS No.: 1423007-82-2
Synonyms: GSK2878175;GSK-175;GSK-175-A
GSK2878175 is a pan-genotypic non-nucleoside NS5B polymerase inhibitor potentially for the treatment of HCV infection.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02014571 | Hepatitis C, Chronic | Phase 1 | Completed | - | Puerto Rico ... more >> GSK Investigational Site San Juan, Puerto Rico, 00927 Collapse << |
NCT01879462 | Hepatitis C, Chronic | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Collapse << |
实验方案
技术信息
CAS号 | 1423007-82-2 | 储存条件 |
|
|
分子式 | C27H23BClFN2O6S | 运输 | 蓝冰 | |
分子量 | 568.81 | 别名 | GSK2878175;GSK-175;GSK-175-A;2878175 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02014571 | Hepatitis C, Chronic | Phase 1 | Completed | - | Puerto Rico ... more >> GSK Investigational Site San Juan, Puerto Rico, 00927 Collapse << |
NCT01879462 | Hepatitis C, Chronic | Phase 1 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Randwick, New South Wales, Australia, 2031 Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网